From pbs.org:
Nationwide, an estimated 1.2 million people are eligible to receive medication that can prevent the spread of life-threatening HIV infection. But only roughly a third of those eligible are currently accessing preexposure prophylaxis, or PrEP, which is seen as key to eventually ending the HIV epidemic in the United States.
A set of new recommendations from the U.S. Preventive Services Task Force endorsed two additional medications approved for PrEP: an oral medication and a long-acting injectable, choices that could help narrow existing disparities and enhance access, particularly in communities of color.
Read more at: https://www.pbs.org/newshour/health/new-prep-medication-recommendation-adds-options-for-hiv-patients
